U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C21H24F3N3O4
Molecular Weight 439.4282
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LASCUFLOXACIN

SMILES

COC1=C2N(CCF)C=C(C(O)=O)C(=O)C2=CC(F)=C1N3C[C@@H](F)[C@@H](CNC4CC4)C3

InChI

InChIKey=ZFIOCUITTUUVPV-MEDUHNTESA-N
InChI=1S/C21H24F3N3O4/c1-31-20-17-13(19(28)14(21(29)30)9-26(17)5-4-22)6-15(23)18(20)27-8-11(16(24)10-27)7-25-12-2-3-12/h6,9,11-12,16,25H,2-5,7-8,10H2,1H3,(H,29,30)/t11-,16+/m0/s1

HIDE SMILES / InChI

Molecular Formula C21H24F3N3O4
Molecular Weight 439.4282
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

LASCUFLOXACIN, a fluoroquinolone derivative, is an antibacterial agent with a broad spectrum of activity against various clinical isolates. It is under development for the treatment of respiratory tract infections and community-acquired pneumonia.

Approval Year

PubMed

PubMed

TitleDatePubMed
In Vitro Activities and Spectrum of the Novel Fluoroquinolone Lascufloxacin (KRP-AM1977).
2017 Jun
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:41:47 GMT 2023
Edited
by admin
on Fri Dec 15 16:41:47 GMT 2023
Record UNII
55MOB566V7
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LASCUFLOXACIN
INN   WHO-DD  
INN  
Official Name English
7-((3S,4S)-3-((CYCLOPROPYLAMINO)METHYL)-4-FLUOROPYRROLIDIN-1-YL)-6-FLUORO-1-(2-FLUOROETHYL)-8-METHOXY-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID
Systematic Name English
3-QUINOLINECARBOXYLIC ACID, 7-((3S,4S)-3-((CYCLOPROPYLAMINO)METHYL)-4-FLUORO-1-PYRROLIDINYL)-6-FLUORO-1-(2-FLUOROETHYL)-1,4-DIHYDRO-8-METHOXY-4-OXO-
Systematic Name English
Lascufloxacin [WHO-DD]
Common Name English
lascufloxacin [INN]
Common Name English
Code System Code Type Description
DRUG CENTRAL
5370
Created by admin on Fri Dec 15 16:41:47 GMT 2023 , Edited by admin on Fri Dec 15 16:41:47 GMT 2023
PRIMARY
WIKIPEDIA
Lascufloxacin
Created by admin on Fri Dec 15 16:41:47 GMT 2023 , Edited by admin on Fri Dec 15 16:41:47 GMT 2023
PRIMARY
SMS_ID
300000019094
Created by admin on Fri Dec 15 16:41:47 GMT 2023 , Edited by admin on Fri Dec 15 16:41:47 GMT 2023
PRIMARY
PUBCHEM
71528768
Created by admin on Fri Dec 15 16:41:47 GMT 2023 , Edited by admin on Fri Dec 15 16:41:47 GMT 2023
PRIMARY
INN
10017
Created by admin on Fri Dec 15 16:41:47 GMT 2023 , Edited by admin on Fri Dec 15 16:41:47 GMT 2023
PRIMARY
EPA CompTox
DTXSID001336967
Created by admin on Fri Dec 15 16:41:47 GMT 2023 , Edited by admin on Fri Dec 15 16:41:47 GMT 2023
PRIMARY
CAS
848416-07-9
Created by admin on Fri Dec 15 16:41:47 GMT 2023 , Edited by admin on Fri Dec 15 16:41:47 GMT 2023
PRIMARY
NCI_THESAURUS
C166817
Created by admin on Fri Dec 15 16:41:47 GMT 2023 , Edited by admin on Fri Dec 15 16:41:47 GMT 2023
PRIMARY
FDA UNII
55MOB566V7
Created by admin on Fri Dec 15 16:41:47 GMT 2023 , Edited by admin on Fri Dec 15 16:41:47 GMT 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
TARGET ORGANISM->INHIBITOR
TARGET ORGANISM->INHIBITOR
TARGET ORGANISM->INHIBITOR
TARGET ORGANISM->INHIBITOR
TARGET ORGANISM->INHIBITOR
TARGET ORGANISM->INHIBITOR
TARGET ORGANISM->INHIBITOR
TARGET ORGANISM->INHIBITOR
TARGET ORGANISM->INHIBITOR
TARGET ORGANISM->INHIBITOR
TARGET ORGANISM->INHIBITOR
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY